Molecular epidemiology of drug-resistant malaria in western Kenya highlands
Open Access
- 31 July 2008
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 1-7
- https://doi.org/10.1186/1471-2334-8-105
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Reconciling national treatment policies and drug regulation in KenyaHealth Policy and Planning, 2007
- Return of Chloroquine Antimalarial Efficacy in MalawiNew England Journal of Medicine, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of KenyaAntimicrobial Agents and Chemotherapy, 2004
- Reemergence of Chloroquine‐SensitivePlasmodium falciparumMalaria after Cessation of Chloroquine Use in MalawiThe Journal of Infectious Diseases, 2003
- A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in TanzaniaInfection, Genetics and Evolution, 2002
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- PCR and strain identification in Plasmodium falciparumParasitology Today, 1993